Nova Patents
ATE235232T1

Lozenge for the modified releasing of active substances in the gastrointestinal tract

Abstract

A pharmaceutical lozenge for the modified release of active compounds in the gastrointestinal tract is described, with active-compound-containing particles which have a first coating controlling the release and a further, outer coating with saliva-resistant properties. The first coating, which controls the release of active compound, can have release-delaying or enteric properties.

Term

Term ended

Projected expiry passed 17 November 2017, 8.9 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

21 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
19648576GermanyA
9706395European Patent Office (EPO)W

Members21

Family members, oldest first
DocumentOfficeKind
CA2272442A1CanadaA1
DE19648576A1GermanyA1
WO9823262A2World Intellectual Property Organization (WIPO)A2
AU5322598AAustraliaA
WO9823262A3World Intellectual Property Organization (WIPO)A3
NO992477D0NorwayD0
NO992477LNorwayL
DE19648576C2GermanyC2
EP0941070A2European Patent Office (EPO)A2
KR20000057205ARepublic of KoreaA
AU725493B2AustraliaB2
US2001001668A1United States of AmericaA1
US6270798B2United States of AmericaB2
JP2001527526AJapanA
EP0941070B1European Patent Office (EPO)B1
AT235232TAustriaT
ATE235232T1This recordAustriaT1
DE59709645D1GermanyD1
ES2196381T3SpainT3
KR100429489B1Republic of KoreaB1
CA2272442CCanadaC